United States · FDA National Drug Code directory
BUPROPION HYDROCHLORIDE (SR)
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43598-863_4486fd29-bab2-59ee-e063-6294a90a4fd2
- Product NDC
- 43598-863
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Bupropion Hydrochloride
- Labeler
- Dr. Reddy's Laboratories Inc
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160817
- Source listing expiry
- 20261231
Source-listed ingredients
- BUPROPION HYDROCHLORIDE — 150 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-10) · 43598-863-10
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-30) · 43598-863-30
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (43598-863-60) · 43598-863-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →